Reportedly, data from the IMROZ study marks the first time an anti-CD38 monoclonal antibody combined with standard-of-care therapy has demonstrated significant improvement in progression-free survival ...

Medical technology company Becton, Dickinson, and Company (BD) announced that it will acquire Edwards Lifesciences’ Critical Care Product Group for $4.2 billion in cash. According to a press release, ...

In an interview with Pharm Exec Associate Editor Don Tracy, Karen Rodriguez-Lorenc, Global Program Head of Linvoseltamab, ...

The continuous digitization of the life sciences industry has significantly increased the volume of medical data. Forecasts suggest that by 2025, global healthcare-related data will reach an estimated ...

Results of the ADRIATIC trial indicated that treatment with Imfinzi after standard-of-care concurrent chemoradiotherapy ...

FDA acknowledged that Astellas has resubmitted zolbetuximab for a Biologics License Application (BLA). 1 The drug is a ...

ConcertAI announced predictive and generative AI solutions, along with a variety of other products, at the 2024 ASCO Annual Meeting. While all of the products are aimed at improving research and ...

The Tarsus Pharmaceuticals CEO discusses the ways that his company is finding solutions that may have been overlooked. Bobby Azamian, CEO and chairman at Tarsus Pharmaceuticals, is focused on finding ...

Under terms of the deal, Akili will become a wholly owned subsidiary of Virtual Therapeutics, with Akili shareholders ...

Fast track designation for AV-001 comes amid promising results from a Phase I trial, which supported once-daily dosing and ...

Multiple surveys show that older voters are concerned about the cost of healthcare and Medicare, along with other financial ...

Approval of Onyda XR marks the first liquid non-stimulant medication for attention-deficit hyperactivity disorder to hit the ...